Scarica l'app Stockscreener
191.25
1.94%
3.64
Dopo l'orario di chiusura:
191.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$187.61
Aprire:
$188.11
Volume 24 ore:
1.77M
Relative Volume:
1.83
Capitalizzazione di mercato:
$21.28B
Reddito:
$10.52B
Utile/perdita netta:
$999.00M
Rapporto P/E:
22.87
EPS:
8.3628
Flusso di cassa netto:
$1.22B
1 W Prestazione:
+2.30%
1M Prestazione:
+3.58%
6M Prestazione:
+12.18%
1 anno Prestazione:
+16.69%
Intervallo 1D:
$187.80
$193.76
Intervallo di 1 settimana:
$184.18
$193.76
Portata 52W:
$148.70
$197.55
Quest Diagnostics Inc Stock (DGX) Company Profile
Nome
Quest Diagnostics Inc
Settore
Industria
Telefono
(973) 520-2700
Indirizzo
500 PLAZA DRIVE, SECAUCUS
Confronta DGX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
191.25 | 20.87B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
587.48 | 215.18B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.39 | 156.94B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
725.91 | 55.05B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
151.25 | 41.12B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
224.90 | 36.97B | 15.90B | 1.28B | 2.21B | 7.2842 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | Iniziato | Redburn Atlantic | Buy |
| 2025-03-04 | Downgrade | Citigroup | Buy → Neutral |
| 2025-01-06 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | Ripresa | Jefferies | Buy |
| 2024-10-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | Ripresa | Evercore ISI | In-line |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-02-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-12-12 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-06-29 | Iniziato | Piper Sandler | Neutral |
| 2023-05-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-03 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-01-23 | Iniziato | Evercore ISI | In-line |
| 2022-11-17 | Downgrade | Citigroup | Neutral → Sell |
| 2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-04-04 | Downgrade | Citigroup | Buy → Neutral |
| 2022-02-23 | Downgrade | UBS | Buy → Neutral |
| 2022-02-02 | Downgrade | Jefferies | Buy → Hold |
| 2022-01-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-05-04 | Aggiornamento | UBS | Neutral → Buy |
| 2021-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | Aggiornamento | Argus | Hold → Buy |
| 2020-07-29 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-06-09 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-04-28 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-04-27 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | Downgrade | Goldman | Neutral → Sell |
| 2019-04-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-03-18 | Ripresa | Credit Suisse | Neutral |
| 2019-01-31 | Downgrade | Argus | Buy → Hold |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2019-01-03 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | Downgrade | Goldman | Buy → Neutral |
Mostra tutto
Quest Diagnostics Inc Borsa (DGX) Ultime notizie
Is Quest Diagnostics Incorporated stock nearing a technical breakout2025 Analyst Calls & Technical Pattern Alert System - newser.com
Is Quest Diagnostics Incorporated (QDI) stock protected from inflationQuarterly Performance Summary & Expert Curated Trade Ideas - newser.com
How Quest Diagnostics Incorporated stock performs in rate cut cyclesQuarterly Portfolio Review & AI Driven Price Predictions - newser.com
Quest Diagnostics (DGX) Up 2.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Quest Diagnostics Stock Outlook: Is Wall Street Bullish or Bearish? - Yahoo Finance
How Quest Diagnostics Incorporated stock valuations compare to rivalsQuarterly Earnings Summary & Verified Stock Trade Ideas - newser.com
Can Quest Diagnostics Incorporated (QDI) stock deliver strong annual returnsChart Signals & Real-Time Chart Pattern Alerts - newser.com
How Quest Diagnostics Incorporated stock benefits from global expansionTake Profit & Expert Curated Trade Setup Alerts - newser.com
Is Quest Diagnostics Incorporated (QDI) stock good for long term investingPortfolio Growth Summary & Consistent Profit Focused Trading Strategies - newser.com
Will Quest Diagnostics Incorporated stock profit from fiscal stimulus2025 AllTime Highs & Detailed Earnings Play Alerts - newser.com
Published on: 2025-11-19 23:07:04 - newser.com
Using flow based indicators on Quest Diagnostics IncorporatedJuly 2025 Outlook & Safe Capital Preservation Plans - newser.com
What Fibonacci levels say about Quest Diagnostics Incorporated reboundIPO Watch & Weekly Top Stock Performers List - newser.com
Published on: 2025-11-19 13:33:19 - newser.com
Is Quest Diagnostics Incorporated (QDI) stock positioned for secular growthPrice Action & Advanced Swing Trade Entry Plans - newser.com
Why analysts maintain buy rating on Quest Diagnostics Incorporated stockJuly 2025 Setups & Verified Technical Signals - newser.com
Will Quest Diagnostics Incorporated stock gain from lower inflationJuly 2025 Review & Safe Capital Investment Plans - newser.com
Published on: 2025-11-19 01:41:12 - newser.com
Why Quest Diagnostics Incorporated stock is a strong buy callMarket Weekly Review & High Conviction Buy Zone Picks - newser.com
Published on: 2025-11-19 00:41:47 - newser.com
Why millennials buy Quest Diagnostics Incorporated stock2025 Technical Overview & Safe Capital Growth Stock Tips - newser.com
Published on: 2025-11-18 23:34:07 - newser.com
Will Quest Diagnostics Incorporated (QDI) stock beat international competition - newser.com
How Quest Diagnostics Incorporated stock trades before earningsJuly 2025 Technicals & Real-Time Volume Analysis Alerts - newser.com
Baird Adjusts Quest Diagnostics Price Target to $198 From $197, Maintains Neutral Rating - MarketScreener
Quest Diagnostics Inc Azioni (DGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):